1. Home
  2. IMSRW vs FBIOP Comparison

IMSRW vs FBIOP Comparison

Compare IMSRW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IMSRW

Terrestrial Energy Inc. Warrant

N/A

Current Price

$3.11

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Fortress Biotech Inc.

FBIOP

Fortress Biotech Inc.

N/A

Current Price

$13.37

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMSRW
FBIOP
Founded
N/A
N/A
Country
United States
United States
Employees
74
101
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
IMSRW
FBIOP
Price
$3.11
$13.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.3K
11.2K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$5.03
52 Week High
$7.01
$14.64

Technical Indicators

Market Signals
Indicator
IMSRW
FBIOP
Relative Strength Index (RSI) 54.85 48.64
Support Level $2.70 $12.63
Resistance Level $3.91 $14.47
Average True Range (ATR) 0.24 0.47
MACD 0.05 -0.05
Stochastic Oscillator 88.00 40.54

Price Performance

Historical Comparison
IMSRW
FBIOP

About IMSRW Terrestrial Energy Inc. Warrant

Terrestrial Energy Inc is a technology company engaged in the development and commercialization of nuclear power plants. The company is focused on its proprietary Integral Molten Salt Reactor (IMSR) technology, a Generation IV reactor design intended to produce reliable, emission-free energy in the form of electricity and high-temperature heat for industrial applications. Its activities mainly involve advancing the design, licensing, and deployment of IMSR plants for commercial energy generation.

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: